New ultrasound model aims to spot dangerous placenta condition before delivery
NCT ID NCT07236060
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether detailed 2D and 3D ultrasound scans can accurately tell the difference between two serious pregnancy complications: placenta accreta spectrum and uterine scar dehiscence. Researchers will scan 50 women in their third trimester who have a low-lying placenta and a history of C-section. The goal is to create a diagnostic model that helps doctors plan safer deliveries and avoid emergencies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
2D/3D ultrasound doppler
What this could lead to
If successful, this could give doctors a reliable, non-invasive way to tell apart two serious pregnancy complications before delivery, helping them prepare the right surgical team and reduce risks.
What could go wrong
This is a small, early-stage study (50 participants) that hasn't started recruiting yet. The ultrasound model may not be accurate enough to replace current methods, and results may not apply to all hospitals or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACENTA ACCRETA, THIRD TRIMESTER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••